BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2421489)

  • 21. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course.
    Lasson A; Ohlsson K
    Scand J Gastroenterol; 1984 Sep; 19(6):779-86. PubMed ID: 6083596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control mechanism of haemostasis--possible role of natural regulators.
    Nathan IV; Han P; Wong HB
    J Singapore Paediatr Soc; 1987; 29(3-4):176-9. PubMed ID: 2453736
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pi phenotypes of alpha-1-antitrypsin and antiproteases in meningococcal sepsis].
    Ruiz C; Blanco Quirós A; Solís P; Alvarez Guisasola J; Sánchez Villares E
    An Esp Pediatr; 1983 Oct; 19(4):268-78. PubMed ID: 6197915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elastosis in breast carcinoma: II. Association of protease inhibitors with immature elastic fibres.
    Davies JD; Mera SL
    J Pathol; 1987 Dec; 153(4):317-24. PubMed ID: 2448440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human serum proteins indicative for the nutritional status and serum proteinase inhibitors in uncomplicated falciparum malaria.
    Schelp FP; Harinasuta T; Bunnag D; Böhning D; Supawan V; Deininger S; Pongpaew P
    Tropenmed Parasitol; 1983 Dec; 34(4):244-7. PubMed ID: 6198795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of concentrations of C-reactive protein and various plasma protease inhibitors preoperatively for the prediction of postoperative complications.
    Göransson J; Jonsson S; Lasson A
    Eur J Surg; 1998 Feb; 164(2):89-101. PubMed ID: 9537715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the effects of snake venom proteinases on the activity of human plasma C1 esterase inhibitor, alpha 1-antichymotrypsin and alpha 2-antiplasmin.
    Kress LF; Catanese J; Hirayama T
    Biochim Biophys Acta; 1983 Jun; 745(2):113-20. PubMed ID: 6342681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitors.
    Lijnen HR; Wiman B; Collen D
    Thromb Haemost; 1982 Dec; 48(3):311-4. PubMed ID: 6984543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of fibrinolysis in saliva after oral surgery measured by enzymic and immunological methods.
    Gersel-Pedersen N
    Int J Oral Surg; 1979 Jun; 8(3):212-21. PubMed ID: 93090
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antiproteinase activity of alpha 2-macroglobulin].
    Protsenko AV
    Ukr Biokhim Zh (1978); 1984; 56(5):546-9. PubMed ID: 6209837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningococcal infection and proteolytic control.
    Stark JM; Matthews N; Ryley HC; Greenwood BM; Lewis LS; Whittle HC
    J Clin Pathol; 1978 Dec; 31(12):1177-81. PubMed ID: 85637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma protease inhibitors in premature infants: influence of gestational age, postnatal age, and health status.
    Andrew M; Massicotte-Nolan PM; Karpatkin M
    Proc Soc Exp Biol Med; 1983 Sep; 173(4):495-500. PubMed ID: 6193532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of granulocytic proteinases and their inhibitors in the pathogenesis of nonspecific endobronchitis (review)].
    Ogloblina OG
    Vopr Med Khim; 1984; 30(1):3-13. PubMed ID: 6324487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic studies on platelet antiproteases.
    Nalli G; Majolino I; Fornasari PM; Cattaneo G; Malamani GD; Almasio P; Piovella F; Ascari E
    Haematologica; 1978 Apr; 63(2):156-62. PubMed ID: 79518
    [No Abstract]   [Full Text] [Related]  

  • 35. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
    Kress LF
    J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma proteinases, proteinase inhibitors and other selective plasma proteins following aortofemoral bypass operation.
    Hörl M; Sperling M; Mayer J; Hörl WH
    Eur Surg Res; 1986; 18(2):69-79. PubMed ID: 2423335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement and protease inhibitors in the mucocutaneous lymph node syndrome.
    Rieger CH; Kawasaki T; Yanase Y; Pollack U
    Eur J Pediatr; 1983 Apr; 140(2):92-7. PubMed ID: 6192994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Status of the inhibitor system of proteolysis enzymes in acute cholecystitis and pancreatitis].
    Protsenko AV; Starosek VN; Protsenko VA
    Sov Med; 1981; (7):16-20. PubMed ID: 6170117
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in fibrinolysis in liver cirrhosis].
    Fontcuberta J; Borrell M; Felez J; Elez I; López M; Remacha A; Rutllant ML
    Sangre (Barc); 1982; 27(4-B):727-36. PubMed ID: 6186038
    [No Abstract]   [Full Text] [Related]  

  • 40. Ten-year changes of protease inhibitors in the sons of patients with COPD.
    Yoshioka A; Nagata H; Yamamoto M; Akiyama Y; Nishimura M; Miyamoto K; Kishi F; Kawakami Y
    Ann N Y Acad Sci; 1991; 624():359-61. PubMed ID: 1712158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.